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Matrix-assisted laser desorption-ionization (MALDI) mass spectrometry was investigated as 
a method for the rapid determination of the extent of polymer coupling in polyethylene 
glycol- (PEG) conjugated superoxide dismutase (SOD). PEG-conjugated SOD, an antioxidant 
with an extended in vivo circulation lifetime compared to that of superoxide dismutase, is 
being evaluated as an effective therapeutic agent for the treatment of injuries and arthritis. 
The mass spectra of a standard batch of PEG-conjugated bovine SOD showed the presence of 
identifiable and well resolved peaks that correspond to O-7 PEG molecules attached to 
bovine SOD. The area of each of the peaks provides a determination of the amount of 
PEG-conjugated SOD with a given number of bound PEG groups. SOD is a noncovalent 
dimer of two identical subunits that dissociates in MALDI. The information obtained in the 
mass spectra thus corresponds to a monomer of SOD. Each SOD monomer contains 10 
lysines, which are the sites of PEG-conjugation. Multiple MALDI determinations of two 
batches of samples indicated good reproducibility for routine determination of the extent of 
polymer content. The amount of PEG-conjugated SOD that contained a given number of PEG 
molecules, determined by MALDI, was compared with the value deduced from the amount 
of PEG-conjugation at each attachment site measured by a peptide mapping method. 
Agreement between the data obtained in the two techniques (MALDI and peptide mapping) 
indicates that MALDI may be used to obtain quantitative information on PEG-conjugated 
SOD to determine the amounts of PEG-conjugated protein each with a different number of 
PEG groups attached. Measurement of several batches of samples stored at a higher 
temperature showed a lower extent of PEG-conjugation in PEG-conjugated SOD. This 
reduction in the PEG content resulted from the PEG-deconjugation of PEG-conjugated SOD 
at a higher temperature. Thus, MALDI can be used to examine the stability of PEG-con- 
jugated SOD. The high sensitivity, relatively straightforward data interpretation, speed of 
analyses, and good reproducibility in measurements make this technique a useful analytical 
tool for fingerprinting PEG-conjugated SOD as well as potentially other polymer-conjugated 
proteins. (I Am Sot Mass Spectrom 1995, 6, 478-487) 
U se of proteins and modified protein materials as therapeutic agents has increased signifi- cantly in recent years as a result of the in- 
creased understanding of the function of these proteins 
and because of the advancement of the technologies 
for their isolation, large scale preparation, and charac- 
terization. Many proteins do not have sufficient serum 
stability to be an effective drug, and the exogenous 
proteins are found to possess immunogenicity. To cir- 
cumvent these problems proteins have been modified 
for therapeutic use. One approach to modification in- 
volves the covalent attachment of water-soluble poly- 
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mers such as polyethylene glycol (PEG) to the protein 
molecules. It has been shown that the attachment of 
polyethylene glycols to proteins (1) reduces, modifies, 
and in some cases eliminates the imrmmogenicity of 
immunogenic proteins, (2) extends the in vivo circula- 
tion lifetime, (3) enhances the solubility, (4) increases 
the stability of proteins by reduction of the tendency 
for aggregation, and (5) increases their potency, which 
facilitate more effective use as drugs [l-91. These ad- 
vantages of protein modification by polymer attach- 
ment have been discussed for a number of proteins 
that include catalase [31, interleukin-2 [4], bovine serum 
albumin [5], superoxide dismutase [6], horseradish 
peroxidase [7], streptokinase 181, asparaginase [9], 
hirudin [lo], adenosine deaminase [ill, and stem cell 
factor [121. In addition, polyethylene glycol-conjugated 
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liposomes have been investigated as a target for the 
treatment of solid tumors [13]. 
Conjugation of polymers with proteins produces a 
heterogeneous mixture of species with a distribution of 
molecular weights. The heterogeneity originates from 
the different probabilities of attachments at different 
locations in the protein as well as the polydispersity of 
the polymer. Two types of heterogeneity arise from the 
differences in the attachment probabilities: 
1. The attachment of polymers results in a different 
number of polymers per mole of protein. 
2. For the same number of attached polymer groups 
there are many different possibilities for the attach- 
ment, which results in different molecular struc- 
tures. 
The polymers are usually covalently attached to pro- 
teins through the oamino groups of lysine residues 
[2-121, although linkings also have been made via 
thioethers of cysteine residues [14]. The conditions that 
are typically used for the PEG-attachment to proteins 
result in the incorporation of a different number of 
PEG molecules per mole of protein. The potency of 
protein-polymer complexes may depend on the extent 
of conjugation, which must therefore be established 
before the material can be considered as a potential 
drug. As a result, the characterization of polymer- 
protein complexes has generated a lot of interest in 
recent years. 
A number of techniques reported for the characteri- 
zation of protein-polymer conjugates include classical 
protein characterization methods, such as chromatog- 
raphy, capillary electrophoresis, light scattering, iso- 
electric focusing, polyacrylamide gel electrophoresis 
[6a, 6b, 10,15,161, and mass spectrometry [12b, 17,181. 
The classical techniques do not provide sufficient reso- 
lution to resolve all of the protein species that contain 
different numbers of polymer units. Vestling et al. [17, 
181 recently described a method for the characteriza- 
tion of PEG-conjugated superoxide dismutase (SOD) 
using mass spectrometry. In this procedure, the PEGS 
are removed from the protein by treatment with a base 
and the protein is left with a succinyl marker at the 
site of attachment. The PEG-deconjugated protein is 
then subjected to peptide mapping by using conven- 
tional and tandem mass spectrometry for the identifi- 
cation of the site of attachment by identification of the 
site of the marker and determination of the amount of 
PEG attached to each site by isotope labeling experi- 
ments [18]. This method provides a measurement of 
the extent of protein-PEG-conjugation at different sites. 
Unfortunately, the method involves complicated and 
time-consuming mass spectrometry operations that 
cannot be applied easily for routine determinations of 
sample stabilities. More recently, Watson et al. [12bl 
used matrix-assisted laser desorption-ionization 
(MALDI) mass spectrometry [19] to obtain a spectrum 
of stem cell factor coupled with PEG molecules. The 
mass spectrum showed resolved peaks of PEG-con- 
jugated stem cell factor that correspond to 1,2,3, and 4 
PEGS attached to stem cell factor [12b]. However, a 
detailed account was not given of the reproducibility 
of this technique for the determination of PEG-con- 
jugated proteins, detection limit, and how the MALDI 
data compared with data from other measurements. 
In the present report we describe the utility of 
matrix-assisted laser desorption-ionization (MALDI) 
mass spectrometry as a method for the rapid determi- 
nation of (1) product heterogeneity that results from 
the different number of PEG molecules attached, (2) 
comparison with the data obtained from other meth- 
ods, and (3) its ease of use for the determination of 
lot-to-lot variation for quality control and stability te’st- 
ing of PEG-conjugated SOD. Furthermore, the repro 
ducibility of measurements of PEG-conjugated SOD by 
MALDI was investigated. 
Superoxide dismutase is an important enzyme that 
plays a vital role in human physiology. It catalyzes the 
destruction of the 0; free radical (eq 1): 
20;+ 2H++ 0, + H,O, (1) 
Superoxide dismutase protects oxygen-metabolizing 
cells against harmful effects (such as aging, lipid per- 
oxidation, and peroxidative hemolysis of red blood 
cells) of superoxide free radicals [20] and hyaluronate 
against depolymerization by free radicals. Other thera- 
peutic utilities of SOD and PEG-conjugated SOD in- 
clude antiinflammatory effects [211 and treatment for 
injuries [22]. The PEG-conjugated bovine superoxide 
dismutase (pegorgotein)’ samples used in the present 
investigation were synthesized by the reaction of 
bovine SOD with PEG reagents [6c] of approximate 
molecular weight of 5000 [16-181. The bovine SOD in 
its native form consists of two identical subunits, each 
of which contains 151 amino acids that include 10 
lysines and an acetylated amino terminus [231. Because 
lysines were targeted for the attachment of PEG to 
SOD, there are 10 possible sites of attachment per 
monomer. We describe a method that provides rapid 
fingerprinting of PEG-conjugated SOD samples that 
determines the number of PEGS attached to SOD and 
quantitates the amounts of PEG-conjugated SOD each 
with a different number of PEG units. Data presented 
here originate from the measurements of eight differ- 
ent batches of PEG-conjugated SOD samples prepared 
separately with different preparations of PEG, of dif- 
ferent lifetime, and stored under different experimen- 
tal conditions. 
’ Superoxide dismutase from bovine origin as Cu-Zn mixed chelate 
with enzyme activity is also known as orgotein (United States Phar- 
macopeial Convention, Inc., C. A. Fleeger, Ed., 1993, pp 462). Hence 
the PEG-conjugated bovine SOD is called pegorgotein. The Sanofi 
Winthrop, Inc. proprietary name of pegorgotein is DismutecTM. Pe- 
gorgotein also has been mentioned as PEG-SOD in the literature. 
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Experimental 
The PEG-conjugated SOD samples used in the present 
investigation were prepared via the procedure [gal 
discussed elsewhere [16-181. Briefly, polyethylene gly- 
co1 of approximate molecular weight 5000 was acti- 
vated by conversion of the free hydroxyl group at one 
end of the polymer to a succinylsuccinimide; the other 
end was capped with a methoxyl group. The activated 
PEG was then converted to PEG-conjugated SOD by 
reaction with bovine SOD at pH 7.8. The activated 
PEG reacts with the primary amines of SOD [9a, 16-181. 
Eight batches of PEG-conjugated SOD samples (Sl 
through S8 studied here) differ from each other in their 
lifetime, type of PEG used to prepare them, storage 
temperature, and so forth. These parameters are given 
in Table 1. The polydispersity of one batch of PEG 
examined was 1.04. 
The MALDI data were acquired on a Finnigan-MAT 
Vision-2000 time-of-flight mass spectrometer (Bremen, 
Germany) [24] equipped with an ion reflectron system. 
The experiments were carried out at Charles Evans 
and Associates (Redwood City, CA). All the data pre- 
sented here were obtained in the reflectron mode of 
operation. Laser radiation of 337~run wavelength gen- 
erated by a N, laser (Laser Science Inc., Newton, MA) 
at 3-ns pulse width was used to produce ions of 
PEG-conjugated SOD from a stainless steel target on 
which a sample solution was codeposited with that of 
a matrix in equal volumes (0.5 ILL each). Sample solu- 
tions were prepared by dilution of the original PEG- 
conjugated SOD solution (- 8 mg/mL) in distilled 
water (Fluka, Ronkonkoma, NY) to a concentration of 
20 (uM, assuming an average molecular weight of 
36,000. The matrix solution was prepared in two steps 
1251. In the first step, a lo-mg/mL solution of 2,5-dihy- 
droxy benzoic acid (Aldrich Chemical Co., Milwaukee, 
WI; 99% pure) was prepared in 65% of 0.1% aqueous 
trifluoroacetic acid (Spectrum Chemicals, Los Angeles, 
CA) and 35% acetonitrile (high-performance liquid 
chromatography grade; Sigma Chemical Co., St. Louis, 
MO) and a solution of 2-methoxy,5-hydroxy benzoic 
acid (Aldrich; 99% pure) of the same concentration 
was prepared in equal volumes of water and ethanol. 
In the second step, these two matrix solutions were 
mixed at a ratio of 9:l v/v, respectively, to obtain the 
final matrix solution that was codeposited on the probe 
tip with the sample solution. After the sample-matrix 
solution dried, the probe tip was inserted into the 
vacuum of the mass spectrometer for MALDI. Data 
from 100 laser shots were summed to obtain the final 
spectrum. The mass-to-charge ratio scale of the data 
was calibrated by using protonated ions of the 
monomer and dimer of SOD. The area of the ion peaks 
was deduced by using the Finnigan-MAT data system 
with a manual assignment of the horizontal baseline 
for individual peaks. The ions initially were acceler- 
ated from the sample target with a translational energy 
of 3 keV and postaccelerated by another 20 keV prior 
to detection. 
Results and Discussion 
Muss Spectra of Polyethylene Glycol-Conjugated 
Superoxide Dismufase 
A MALDI spectrum of the standard batch (Sl) of 
PEG-conjugated SOD sample is shown in Figure 1. The 
spectrum shows the presence of eight peaks desig- 
nated with numerals O-7 with m/z values of 15,603, 
20,745, 25,995, 31,093, 36,265, 41,496, 46,648, 51,600, 
respectively. The number on each peak, shown below 
the mass-to-charge ratio values, corresponds to the 
number of PEG groups present in the PEG-conjugated 
SOD molecules. As mentioned previously, PEG- 
conjugated SOD in solution consists of two noncova- 
lently attached subunits of SOD backbone attached to 
PEG. Each SOD molecule with an acetylated amino 
terminus has 10 lysines to which PEG molecules can 
attach. During the MALDI the two noncovalently held 
Table 1. Jnformation on the lifetime, storage temperature, PEG, and preparation of eight batches 
of PEG-conjugated SOD examined here 
Sample 
i.d. 
Sl 
s2 
s3 
s4 
s5 
S6 
s7 
S8 
Activated 
PEG i.d. 
Batch 1 
Batch 2 
Batch 3 
Batch 3 
Batch 4 
Batch 4 
Batch 5 
Batch 6 
Diol contenta 
of the PEG 
(%I 
-3 
-30 
-3 
-3 
-3 
-3 
-3 
-3 
Lifetime 
(months) 
15 
56 
36 
36 
36 
36 
12 
6 
Storage 
temperature 
(“Cl 
-20 
5 
5 
15 
5 
15 
5 
5 
‘The diol content of a sample is the amount of PEG that contains two hydroxyl groups. The PEG in 
the sample is expected to have one hydroxy group in one end and a methoxy group at the other. The 
hydroxyl group is used to couple to proteins. Thus the diols will have a free hydroxyl group after 
conjugation with a SOD molecule. 
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Figure 1. Matrix-assisted laser desorption-ionization spectrum of the PEG-conjugated SOD sample 
Sl. The numbers on the peaks designated O-7 indicate the number of PEG molecules attached. The 
numbers at the top of the spectrum are the centroided mass-to-charge ratio values of the 
corresponding peaks. Approximately 10 pmol of the sample was deposited on the probe tip. The 
spectrum was obtained by summing the spectra from 
root mass-to-charge ratio scale. - - 
106 individual laser shots. Note the square 
subunits dissociate and a spectrum that corresponds to 
one PEG-conjugated SOD subunit is observed. In Fig- 
ure 1 up to seven PEG molecules were identified to be 
attached to SOD monomers. Each of the adjacent peaks 
designated O-7 is determined to be separated by ap- 
proximately 5000 u. This value agrees with the average 
molecular weight of PEG used to prepare PEG- 
conjugated SOD. Therefore, these adjacent peaks differ 
by one PEG unit. The area of each peak provides 
information on the amount of PEG-conjugated SOD 
that contains the number of PEG molecules identified 
by the number in Figure 1. Thus, the spectrum (Figure 
1) provides a rapid fingerprinting of PEG-conjugated 
SOD on the distribution of attached PEG. The mass- 
to-charge ratio values shown at the top of the spec- 
trum correspond to the centroids of the peaks. The 
intensity distribution within any given ion peak in 
Figure 1 corresponds, in the most part, to the polydis- 
persity of the attached PEG. 
The molecular weight of a SOD monomer is 15,592. 
Therefore, the peak designated 0 in Figure 1 may be 
considered to arise from a SOD monomer. However, 
observation of this peak in the mass spectrum does not 
necessarily indicate the presence of PEG-free SOD in 
the PEG-conjugated SOD sample. This peak may origi- 
nate from two different sources. 
Those PEG-conjugated SOD molecules (dimers in 
solution) with PEG on only one of the SOD 
monomers will produce equimolar amounts of SOD 
with PEG and SOD without PEG upon dissociation. 
Therefore, one can expect to see SOD monomer ions 
in the MALDI spectra even if the PEG-conjugated 
SOD sample contains no PEG-free SOD. 
The mass-to-charge ratio value of the peak desig- 
nated 0 (15,603) is approximately half of that of the 
peak designated 3 (m/z 31,093). Thus, a small dou- 
bly charged ion contribution of PEG-conjugated SOD 
with three PEG molecules will appear at the peak 
designated 0. 
There is also a third possibility that may contribute to 
that peak; PEG-conjugated SOD molecules that would 
undergo decomposition during MALDI with the elimi- 
nation of attached PEGS (covalent dissociation) will 
occur also at peak 0. However, the data presented 
below provide evidence to support the absence of any 
significant on-target (prompt) fragmentation of PEG- 
conjugated SOD under the present MALDI experimen- 
tal conditions. All the data presented here were ac- 
quired with near threshold laser fluence required to 
produce ion desorption from PEG-conjugated SOD. 
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We have investigated the contribution of ions with 
two charges. As shown in Figure 1, the ion peak (m/z 
18,153) located between the peaks designated 0 and 1 
most likely arises from a PEG-conjugated SOD 
molecule that contains four PEG per monomer with 
two charges. This PEG-conjugated SOD ion peak with 
two charges is free of interference from other ions and 
was used to determine the 2+ ion contribution of 
PEG-conjugated SOD from 10 different sets of data 
points. In addition, data from two other peaks also 
were used to deduce the 2+ ion contribution. The 
amount of PEG-conjugated SOD ions with two charges 
was calculated from the spectra to be 16 f 4% relative 
to that of PEG-conjugated SOD ion with only one 
charge, where both had the same number of PEG 
groups. The peak 0 in Figure 1 is only 3.2% of the total 
PEG-conjugated SOD contribution, whereas peak 3 is 
19.3%. The calculated 2 + ion contribution in peak 0 is 
3.1% (16% of 19.3 is 3.1). In other words, the ion 
abundance in peak 0 (Figure 1) is very close to that 
which can be expected from the 2 + ion contribution of 
PEG-conjugated SOD with three PEGS (assuming a 
similar 2 + ion contribution of PEG-conjugated SOD 
molecules that contain three and four PEG groups). 
This observation suggests the absence of PEG-free SOD 
in the PEG-conjugated SOD sample and is in agree- 
ment with the detection of no free SOD molecules in 
gel permeation chromatographic measurement of 
the sample Sl. Furthermore, the observation of only 
3.2% abundance of peak 0 eliminates the possibility of 
prompt fragmentation of PEG-conjugated SOD ions to 
SOD ions in the present MALDI experimental condi- 
tions. In addition, the peakwidth at half-maximum of 
the peak designated 0 in Figure 1 is larger than that 
which is typically observed for the 1 + ion of SOD and 
is approximately half the width of the peak designated 
3. The 2+ ion contribution observed by Watson et al. 
[12bl in the MALDI spectra of PEG-conjugated stem 
cell factor, however, appears to be much higher than 
that observed for PEG-conjugated SOD in the present 
investigation (Figure 1). This difference in the 2 + ion 
contribution could be due to, among others, the dif- 
ferent protein backbones (stem cell factor versus SOD) 
involved and/or the different matrix materials used. 
Watson et al. [12b] used sinapinic acid as the matrix, 
whereas a mixture of 2,5-dihydroxy benzoic acid and 
2-hydroxy,5-methoxy benzoic acid [WI was used in the 
present studies. The smaller 2 + ion contribution ob- 
served in the present study reduces the spectral com- 
plexity and is particularly important in the case of 
spectra of PEG-conjugated SOD in which 2 + ion peaks 
unfortunately overlap with some of the peaks from 1 + 
ions. 
Reproducibility of Measurements and 
Detection Limit 
To establish whether the technique can be used to 
fingerprint PEG-conjugated SOD for the determination 
of the extent of PEG-conjugation, the reproducibility in 
the MALDI measurements of PEG-conjugated SOD 
samples was investigated. The standard sample Sl was 
prepared separately, examined by the MALDI method 
nine times on three different dates, and measured 
between other batches of samples. The intensity values 
were deduced from the area of each peak that corre- 
sponded to the different number of PEG groups (see 
Figure 1). The average data of nine measurements 
together with the standard deviation of the data points 
are shown in Figure 2. The standard deviation of ion 
abundances is typically 7-15% for the abundant peaks, 
which are at least 13% of the total ion abundance, 
whereas the weaker peaks gave a larger deviation 
(Table 2). The higher standard deviation for weaker 
peaks (less than 10% of the total abundance) arises 
from the higher uncertainties involved in the determi- 
nation of the area. The standard deviation obtained in 
three separate measurements of the sample S2, how- 
ever, is much smaller (Table 2). 
The results discussed in the preceding text indicate 
that the MALDI technique could be used to determine 
lot-to-lot variability for quality control and stability 
testing of polymer-conjugated proteins. The intensities 
that correspond to various number of PEG groups 
attached, obtained from the MALDI measurements of 
four samples Sl, S2,57, and S8, are compared in Table 
2. The data on sample Sl are an average of nine 
measurements, those on S2 are an average of three 
measurements, whereas those on samples S7 and S8 
come from single measurements. A comparison of the 
data obtained from samples Sl and S2 presented in 
Table 2 shows a clear difference in the extent of PEG 
attachment in the two samples. 
1. The peak that apparently corresponds to zero num- 
ber of PEG attached per monomer of SOD is much 
higher in sample S2 compared to that in Sl. As 
previously discussed, the intensity that corresponds 
to PEG 0 in Sl is close to that which can be expected 
from the 2+ ion contribution of PEG-conjugated 
SOD that contains three PEGS. The 2 + ion contribu- 
tion of the PEG-conjugated SOD that contains three 
PEGS in S2 is expected to be m 3.2%. This value is 
only one third of what is measured for peak 0 
(Table 2). This higher value for the PEG-conjugated 
SOD monomer ion free of PEG indicates the pres- 
ence of some PEG-free SOD in sample S2. 
2. The intensity of ions of PEG-conjugated SOD that 
contains a higher number of PEG molecules is higher 
in the sample Sl compared to that in 52. Thus, for 
example, in Sl PEG-conjugated SOD ions with four 
and five PEGS are the most intense whereas in S2 
PEG-conjugated SOD ions of 1, 2, and 3 PEGS are 
the most intense (Table 2). The PEG used to synthe- 
size PEG-conjugated SOD sample S2 contained a 
higher proportion of diols ( * 30%) compared to 
only 3% in the PEG used to make samples Sl and 
S3-S8. Furthermore, sample S2 is m 5 years old and 
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Figure 2. The average and standard deviation values of the area of different ion peaks of 
PEG-conjugated SOD obtained from nine separate MALDI measurements. The bars designated O-7 
correspond to PEG-conjugated SOD ion peaks that contain O-7 PEG molecules, respectively. The 
standard deviation observed in the measurements of each peak is shown by the vertical line on top 
of the bar that represents the peak. The measurement conditions were the same as those given for 
Figure 1. 
substantial PEG-deconjugation would be expected 
to have occurred. MALDI data clearly demonstrate 
that there are differences in the PEG content in the 
two samples. 
Samples S7 and S8 were prepared from the same 
batch of PEG that was used to prepare sample Sl 
(Table 2). These samples differ only in their age and 
storage conditions. Sample Sl is 15 months old and 
was stored at -20 “C, whereas samples S7 and 58 are, 
respectively, 12 and 6 months old; both were stored at 
5 “C. The similarity in the mass spectra of Sl, S7, and 
S8 (Table 2) suggests that at the storage temperature of 
5 “C, the PEG-conjugated SOD samples do not degrade 
to a measurable extent within the 1Zmonth duration 
examined here. 
Table 2. Comparison of the intensities of various ion peaks that contain different numbers of PEG 
molecules attached per monomer of SOD observed in the MALDI spectra of four different batches 
of PEG-conjugated SOD sample9 
Number of 
PEG attached Sample Sib Sample S2c Sample S7d Sample S8d 
0 2.9 f 1.1 9.6 f 1.5 4.9 
1 6.1 f 1.2 19.2 f 2.7 4.9 
2 8.8 f 1.6 20.0 f 2.2 6.9 
3 19.2 f 1.6 20.2 f 2.2 12.6 
4. 25.4 f 1.9 15.0 f 2.1 21.5 
5 22.8 f 2.3 10.1 f 0.5 26.3 
6 12.4 f 2.9 4.9 f 0.7 16.6 
7 3.0 f 1.6 - 4.9 
8 - - 1.6 
4.9 
5.2 
8.1 
13.4 
20.4 
26.7 
13.4 
7.6 
1.2 
’ Intensity values are obtained from the area of each peak in the MALDI mass spectra, converted into 
percent of total intensities. No correction for 2+ ion contribution is taken into account. 
b Data from nine difkrent measurements. 
‘Data from three difkrent measurements. 
d Data from a single measurement. 
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All the MALDI data discussed so far were acquired 
from 20-PM sample solutions (approximate MW = 
36,000) with 10 pmol (0.5 PL) deposited on the 
probe (Figure 1, for example). Figure 3 shows PEG- 
conjugated SOD spectra of sample Sl obtained from l- 
(top) and O.l-pmol (bottom) materials. The spectrum 
from I-pmol sample is quite similar to that obtained 
from lo-pm01 sample (Figure 11, although the former 
has a lower signal-to-noise ratio. When the sample 
amount was reduced to 0.1 pmol, the spectrum lacked 
any discernible information (Figure 3). These experi- 
ments suggest that at least 1 pmol of sample may be 
needed to obtain an informative spectrum of PEG- 
conjugated SOD. In homogeneous samples, such as 
SOD, the amount deposited on the probe corresponds 
to a single species. In contrast, in PEG-conjugated SOD 
1 pmol represented thousands of different species with 
different molecular weight. These “thousands of dif- 
ferent species” come from the number of lysines times 
the PEG molecular weight distribution times the popu- 
lation probability per site. As a result, the concentra- 
tion of a given species in the PEG-conjugated SOD 
sample is much lower than has been described. Larger 
quantities of heterogeneous samples, as such, are 
needed to obtain a MALDI spectrum even though the 
detection limit may be as good as those for proteins. 
Determination of the Stability of 
Polyethylene Glycol-Conjugated 
Superoxidase Dismu tase Samples 
Because of good reproducibility of measurements, ease 
of use, rapidity of analyses, and relatively straight- 
forward data interpretation, MALDI can be used rou- 
1 pmole 
4 
8000 14000 21ooo 3oooo 4oooo 52000 65000 80000 
m/z 
Figure 3. MALDI mass spectra of PEG-conjugated SOD sample Sl. The top spectrum was obtained 
from 1.0 pmol and the bottom spectrum from 0.1 pmol of sample deposited on the probe. The 
experimental conditions were the same as those used in acquisition of the spectrum shown in Figure 
1. The top spectrum is similar to that in Figure 1 (10 pmoll, but is of much reduced spectral quality 
(signal to noise). The bottom spectrum does not provide any information on the PEG-conjugated 
SOD sample. These data indicate that at least 1 pmol of PEG-conjugated SOD may be needed to 
obtain a meaningful MALDI spectrum. 
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tinely to determine the stability of polymer-conjugated 
proteins. Figure 4 shows the intensity of PEG- 
conjugated SOD ions plotted against different number 
of PEG groups attached for four different samples-S3, 
54, S5, and 56. S3 and S4 are the same material stored 
at 5 and 15 “C, respectively, for 36 months. Similarly, 
S5 and S6 arise from the same batch of PEG-conjugated 
SOD and were stored at 5 and 15 “C, respectively, for 
the same duration (Table 1). Examination of the data 
presented in Figure 4 demonstrates that in the MALDI 
spectra of samples stored at 15 “C, the intensity distri- 
bution of ions corresponds to a PEG distribution with 
fewer PEGS than those for samples stored at 5 “C. For 
example, the peak that apparently corresponds to 0 
PEG is about 5% in S3, whereas it is higher than 10% 
in S4, and the ion peak that contains four PEGS is 
- 23% in 53 and has been reduced to - 4% in S4. A 
similar ion intensity trend also was observed in the 
MALDI spectra of samples 55 and S6. That is, PEG- 
conjugated SOD molecules in the samples stored at 5 
“C contain a higher number of PEG molecules per 
mole of SOD than those stored at 15 “C. Because there 
is no difference in the experimental conditions used to 
obtain the spectra, the lower PEG content in S4 and S6 
most likely arises from the PEG-deconjugation of these 
samples at a higher temperature. Samples S4 and S6 
may even contain PEG-free SOD (Figure 4). This obser- 
vation was confirmed by the detection of PEG-free 
SOD in the gel permeation chromatographic determi- 
nation of the sample. These results clearly demonstrate 
the utility of the technique to examine the stability of 
the samples for quality control of polymer-attached 
proteins. 
Comparisolz of Matrix-Assisted Laser 
Desorpfion-lonizatorz Data zoifh Those Obtained 
from Other Techniques 
To determine quantitative aspects of the MALDI tech- 
nique for the characterization of polymer-conjugated 
proteins, the data obtained from the peptide mapping 
method by using liquid chromatographic quantitation 
[26] were compared with the data obtained from the 
MALDI analysis. Sample Sl was examined by both 
techniques. In the peptide mapping procedure, the 
PEG-conjugated SOD sample is cleaved into small 
peptides by treatment with Asp-N, an enzyme that 
cleaves at the amino terminus of the acidic residues. 
The peptides that contained nonmodified lysines were 
quantitated from the liquid chromatogram and the 
data were compared with those from the same peptide 
that originated from SOD. The measurements provide 
an estimation of the extent of PEGation at each lysine. 
Data obtained for various lysines in the sample Sl are 
as follows: Lys 3, 45%; Lys 9, 60%; Lys-23, not deter- 
mined; Lys 67, 68, 73, 91%; Lys 89, 66%; Lys 120, 
100%; Lys 134, 45%; Lys 151, 69%. The amount of 
PEG-conjugation at Lys 23 could not be determined 
because the peptide that contained this lysine was not 
detected and Lys 67, 68, and 73 were measured to- 
gether as they appeared in one peptide. For Lys 23, for 
which no peptide mapping data were available, we 
have used data (54% PEG-conjugation) reported by 
Vestling et al. [18] for a different batch of sample, and 
for Lys 67, 68, and 73 we have assumed equal contri- 
bution (30% each) from the three attachment sites. 
These values were used as statistical probabilities Pi 
Effect of Temperature on the Stability of PEG-SOD samples 
% 
25 
a! 
= 
0 
20 
w 
B 
g 15 
3 
3 10 
0 PEG 1 PEG 2PEG 3 PEG 4PW 5 PEG 6PBJ 7pM 
# of PEG atlaohed 
Figure 4. Comparison of the MALDI data of samples S3, S4, 55, and S6. Samples S3 and S4 are the 
same material but stored at 5 and 15 “C, respectively, for 36 months. 55 and S6 arise from the same 
material (but different than S3 and S4) stored at 5 and 15 “C, respectively, for 36 months. S4 and S6 
samples show a much reduced extent of PEG-conjugation compared to S3 and S5. 
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for PEG-conjugation at these sites. Thus P, = 0.45, 
P2 = 0.6, P3 = 0.54, P4 = Ps = Ps = 0.3, P, = 0.66, 
Pa = 0.99, Ps = 0.45, and P,, = 0.69. 
If Pi is the probability of the PEG-conjugation at the 
ith site, then the probability of PEG-conjugated SOD 
molecules that contain different numbers of attached 
PEG groups can be expressed by formula (2): 
fi pp(l _ pi)(W* 
i=l 
(2) 
where ai defines the status of the site i. If the site i is 
PEG-conjugated, then ci = 1; if the site is unoccupied, 
q = 0. For example, if we have only two sites with 
attachment probabilities P, (0.45) and P2 (0.61, for- 
mula (2) reduces to formula (3): 
P,“1(1 - pJ(l-ol) x P,o2(1 - p2)(1-cQ (3) 
From formula (3) the probability of molecules with 
no PEG attached is 0.55 X 0.4 = 0.22 (ai = a, = 01, 
that for one site occupied is 0.45 x 0.4 (a, = 1, u, = 0) 
+ 0.55 x 0.6 (a, = 0, a, = 1) = 0.51, and that for both 
sites occupied is 0.45 X 0.6 = 0.27 (ui = 1, a, = 1). 
These values are expected from the statistical distribu- 
tion of the attachment of PEGS on the two sites with 
probabilities 0.45 and 0.6. 
The number of possibilities, however, increases 
beyond the ability for manual calculation when the 
maximum value of i becomes equal to 10. Therefore, 
based on the formula (2) a computer algorithm was 
developed to calculate the probability of PEG-con- 
jugated SOD molecules that contain different numbers 
of attached PEG groups. The values obtained, based on 
the peptide mapping data, for O-16 attached PEG 
groups,. respectively (in percent), are 0, 0.2, 2.0, 8.3, 
19.0, 26.8, 24.1, 13.8, 4.9; 1.0, and 0. A comparison of 
these values with those obtained from the MALDI data 
(Table 2, Sl), after correction for 2 + ion contributions, 
is given in Figure 5. The two curves that represent data 
from the two sources are strikingly similar except that 
the peptide mapping values predict, for the same 
abundance, one more PEG per SOD monomer. There 
are a number of possibilities for the origin of this 
difference. 
There are uncertainties involved in the determina- 
tion of the probabilities of attachments by peptide 
mapping. The probability P, was obtained from a 
different type of measurement performed on a dif- 
ferent batch of sample [18] and Pa, Ps, and Ps were 
estimates from the total value for the three. 
The discrimination in the desorption and ionization 
of this class of materials in the MALDI is unknown. 
No attempt was made to determine the mass- 
to-charge ratio-dependent detection efficiency of 
polymer-conjugated proteins in the present study. A 
uniform MALDI response independent of molecular 
weight was assumed in the data reported here. 
With all these possible sources of uncertainties, the 
agreement between the two methods is certainly good. 
The preliminary results presented here indicate that 
Comparison of data from MALI31 8nd peptlde mappIng 
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Figure 5. Comparison of the amount (percent of the total) of PEG-conjugated SOD that contains 
different number of PEG groups determined by MALDI with those statistically deduced from the 
percent PEG-conjugation values for each attachment site measured by the peptide mapping method. 
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MALDI may be used to quantitatively determine 
PEG-conjugated proteins within the accuracy observed 
here. Further investigations are underway to increase 
our understanding of the effect of various factors 
that govern the desorption-ionization of polymer- 
conjugated proteins in MALDI. The high sensitivity, 
rapidity in analyses, relatively straightforward data 
interpretation, and good reproducibility in measure- 
ments make MALDI a viable analytical tool for fin- 
gerprinting PEG-conjugated SOD as well as other 
polymer-conjugated proteins [12b]. 
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